End-to-end CDMO services for small molecules
Developing small-molecule drug substances requires robust synthesis, scalable processes and regulatorily ready approaches. Early challenges such as solubility, stability and bioavailability must be addressed while navigating a complex regulatory landscape and increasing expectations for sustainable pharmaceutical manufacturing.
RISE delivers integrated chemistry, process development, analytical and GMP expertise to help pharma and biotech teams progress efficiently from early discovery to clinical-trial API supply. We support small-molecule developers with tailored solutions across route design, process optimisation, solid-state chemistry, analytical characterisation and GMP-compliant production.
From early feasibility to clinical-trial material, we provide data-driven insights, scalable manufacturing strategies and, where required, the safe handling of highly potent active pharmaceutical ingredients (HPAPIs) under strictly controlled conditions. This enables robust development paths that reduce risk and accelerate timelines.
Services and expertise in drug substance development
We support robust and scalable API development through structured process design, regulatorily aligned CMC strategies and GMP-compliant manufacturing, including safe handling of high-potency compounds where required. Explore our offer in more detail or contact us directly to discuss how we can address your challenges.
Contact us
Ready to develop your next pharmaceutical product with us? Reach out and we’ll get back to you shortly.
